TBPH icon

Theravance Biopharma
TBPH

Overview Fund Activity

115 hedge funds and large institutions have $439M invested in Theravance Biopharma in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 43 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
-4
Holders Change %
-3.36%
% of All Funds
1.83%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
12
Increased
30
Reduced
43
Closed
15
Calls
$1.18M
Puts
–
Net Calls
+$1.18M
Net Calls Change
+$1.05M

Top Buyers

1
OMC
1
Oasis Management Company
Cayman Islands
$8.23M
2
GCP
2
GSA Capital Partners
United Kingdom
$2.81M
3
PWAM
3
Park West Asset Management
California
$17.1M
4
HCM
4
Highbridge Capital Management
New York
$1.96M
5
Millennium Management
5
Millennium Management
New York
$1.96M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$137K
2
OM
2
Opaleye Management
Massachusetts
$0
3
Norges Bank
3
Norges Bank
Norway
$0
4
BlackRock
4
BlackRock
New York
$39.4M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$33.1M
Name Holding Trade Value Shares
Change 		Shares
Change %
JF
126
Jump Financial
Illinois
– -$108K -10,434 Closed
Group One Trading
127
Group One Trading
Illinois
– -$31.8K -3,069 Closed
NA
128
NewEdge Advisors
Louisiana
– -$2.25K -217 Closed
2 3 4 5
6